QR-Code

Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma

Introduction: Prospective randomized trials are lacking in extensive-stage or metastatic extra-pulmonary small cell carcinoma (EPSCC). As a result, treatment for EPSCC is largely extrapolated from SCLC studies. Methods: This single-arm phase II trial enrolled patients with EPSCC to investigate the a...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Peey-Sei Kok, PhD, Bryan Chan, MMed (Clin Epi), Mason Aberoumand, MAppStat, Alison Zhang, PhD, Ken O’Byrne, MD, Subotheni Thavaneswaran, PhD, Frank Lin, PhD, Maya Kansara, PhD, Theresa Corpuz, BSc (Hons), Patrick Wheeler, BS, Robert John Simes, PhD, David Thomas, PhD, Chee Khoon Lee, PhD
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2026-07-01
Schriftenreihe:JTO Clinical and Research Reports
Schlagworte:
Small cell
Durvalumab
Chemo-immunotherapy
Extrapulmonary small cell carcinoma
EPSCC
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2666364326000652
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge